Akura Medical, a Shifamed Portfolio Company, Closes $35M in Series B Financing

Akura Medical reports the funds will be used to apply for FDA 510(k) clearance for the Akura Mechanical Thrombectomy Platform, support clinical trials for additional indications, and scale manufacturing capabilities.